{
    "7ea3e0b8-cd7b-3ffc-a359-e8adb36e7b36": {
        "uuid": "7ea3e0b8-cd7b-3ffc-a359-e8adb36e7b36",
        "title": "Viatris and Biocon Biologics Launch Abevmy\u00ae (Bevacizumab), Their Third Oncology Biosimilar, in Canada",
        "publisher": "CNW Group",
        "link": "https://finance.yahoo.com/news/viatris-biocon-biologics-launch-abevmy-105900783.html",
        "providerPublishTime": 1652957940,
        "type": "STORY"
    },
    "1c8cedbc-bce2-3eb5-a40c-05afc9f40f9e": {
        "uuid": "1c8cedbc-bce2-3eb5-a40c-05afc9f40f9e",
        "title": "Viatris Publishes Sustainability Report Highlighting 2021 Progress, Achievements and Goals",
        "publisher": "PR Newswire",
        "link": "https://finance.yahoo.com/news/viatris-publishes-sustainability-report-highlighting-105900704.html",
        "providerPublishTime": 1652698740,
        "type": "STORY"
    },
    "3ec0288f-0467-31d0-9b09-983f9fe45d8b": {
        "uuid": "3ec0288f-0467-31d0-9b09-983f9fe45d8b",
        "title": "2 Stocks That Are Ridiculously Cheap Right Now",
        "publisher": "Motley Fool",
        "link": "https://finance.yahoo.com/m/3ec0288f-0467-31d0-9b09-983f9fe45d8b/2-stocks-that-are.html",
        "providerPublishTime": 1652529120,
        "type": "STORY"
    },
    "be6e5eb4-0384-3310-a69f-3a04720ea650": {
        "uuid": "be6e5eb4-0384-3310-a69f-3a04720ea650",
        "title": "3 Dirt-Cheap Stocks You Can Buy Right Now",
        "publisher": "Motley Fool",
        "link": "https://finance.yahoo.com/m/be6e5eb4-0384-3310-a69f-3a04720ea650/3-dirt-cheap-stocks-you-can.html",
        "providerPublishTime": 1652526240,
        "type": "STORY"
    },
    "f96cfa6d-4709-3a30-911b-860e084bc860": {
        "uuid": "f96cfa6d-4709-3a30-911b-860e084bc860",
        "title": "3 Top S&P 500 Stock Market Gainers Today",
        "publisher": "Investor's Business Daily",
        "link": "https://finance.yahoo.com/m/f96cfa6d-4709-3a30-911b-860e084bc860/3-top-s%26p-500-stock-market.html",
        "providerPublishTime": 1652126782,
        "type": "STORY"
    },
    "a4c08eaa-0272-3407-a4ed-e4d5975cf61b": {
        "uuid": "a4c08eaa-0272-3407-a4ed-e4d5975cf61b",
        "title": "Viatris Posts Q1 Profit Despite 5% Dip In Sales, Reiterates FY22 Guidance Above Consensus",
        "publisher": "Benzinga",
        "link": "https://finance.yahoo.com/news/viatris-posts-q1-profit-despite-174608273.html",
        "providerPublishTime": 1652118368,
        "type": "STORY"
    },
    "00ead437-455f-34a6-91ef-003d5a53613d": {
        "uuid": "00ead437-455f-34a6-91ef-003d5a53613d",
        "title": "Why Viatris Stock Is Popping Today",
        "publisher": "Motley Fool",
        "link": "https://finance.yahoo.com/m/00ead437-455f-34a6-91ef-003d5a53613d/why-viatris-stock-is-popping.html",
        "providerPublishTime": 1652111732,
        "type": "STORY"
    },
    "60ff8d36-4390-32da-bc8b-69ef41ffdd1f": {
        "uuid": "60ff8d36-4390-32da-bc8b-69ef41ffdd1f",
        "title": "Viatris outlines potential depth of share repurchases after divestitures",
        "publisher": "American City Business Journals",
        "link": "https://finance.yahoo.com/m/60ff8d36-4390-32da-bc8b-69ef41ffdd1f/viatris-outlines-potential.html",
        "providerPublishTime": 1652108078,
        "type": "STORY"
    }
}